Key Takeaway: Vor Biopharma is set to participate virtually in the 3rd Annual Oncology Conference hosted by B. Riley Securities on January 18, 2023. The company, which specializes in cell and genome engineering for blood cancer therapies, aims to present its innovative approaches. A live webcast of the event will be available on their website, providing an opportunity for broader engagement. An archived version of the presentation will also be accessible after the event.
Price reaction · baseline $115.2 (2023-01-11 close) · hit after-hours · clean, no other VOR news in the window
day 0 close · peak
+3.8%
Market Sentiment Analysis
POSITIVE FACTORS
Vor Biopharma is participating in a prominent industry conference.
The company focuses on innovative treatments for blood cancers.
The presentation will be accessible to a wide audience through a live webcast.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+442%
120-day peak, hindsight
Typical move
18.8%
average across 6 past catalysts
Cash runway
~55 mo
Minimal dilution risk
Lead asset
Telitacicept
Phase 3 · Primary Sjogren's Disease
Full Press Release Details
CAMBRIDGE, Mass., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Vor Biopharma (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate virtually in B. Riley Securities’ 3rd Annual Oncology Conference.
B. Riley Securities’ 3rd Annual Oncology Conference – Fireside Chat
Date: Wednesday, January 18, 2023
A live webcast of the presentation will be available via the Investors section of the Company's website at www.vorbio.com. An archived replay of the webcast will also be available following the conference.
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.
Frequently Asked Questions
When is Vor Biopharma participating in the conference?
Vor Biopharma will participate on January 18, 2023.
How can I watch the conference live?
The conference will be streamed live on Vor's website.
What is the focus of Vor Biopharma?
Vor Biopharma focuses on cell and genome engineering for blood cancer treatments.
Will there be a replay of the conference?
Yes, an archived replay will be available after the event.